NHNSENarayana Hrudayalaya Ltd.· Healthcare ServicesHighNeutral
Announced Mon, 19 Jan, 2026 · 18:05 IST

ICRA reaffirms Narayana Hrudayalaya credit rating at AA Stable

NH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.4%Reaction day
₹1861.00
prior close
₹1860.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-2.7%+0.3% vs market
Hospital peers, median of 21sector-2.6%+0.3% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Smallcap 250 and 0.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.0
10m
-1.1
15m
-1.0
30m
-1.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.4-2.7+0.3-2.6+0.3
Next day
-2.5-3.4+0.9-3.5+1.0
2d
-4.6-2.5-2.1-3.6-1.0
3d
-6.3-4.4-1.9-5.2-1.2
4d
-6.9-4.2-2.6-5.5-1.4
5d
-5.2-2.4-2.8-4.7-0.5
1w
-5.1-1.6-3.5-4.1-1.0
15d
+0.3+2.2-1.8+3.3-3.0
1m
-1.7-0.4-1.3+2.7-4.4
2m
-11.2-7.7-3.5-8.2-3.0
3m
-3.2+2.2-5.4-0.2-3.0
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

ICRA has reaffirmed Narayana Hrudayalaya's credit ratings at AA (Stable) for long-term and A1+ for short-term across bank facilities totalling Rs 5,195 crore. Rating action supports strong Narayana Health brand, 42-facility network across India and Cayman Islands, and healthy margins (OPM about 23.4-23.5%). Outlook stays Stable despite UK hospital acquisition of around Rs 2,200 crore and large capex plans of Rs 700-800 crore in FY26 and Rs 1,400-1,450 crore in FY27.

Likely market impact

Reaffirmation signals continued credit strength with no negative impact. Near-term debt metrics may moderate due to capex and UK deal, but earnings capability stays supportive.